Bioventix (BVXP) Competitors GBX 2,900 +50.00 (+1.75%) As of 10:54 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider TradesBuy This Stock BVXP vs. SLN, PRTC, OXB, FARN, HZD, VRP, ARIX, 4BB, CIR, and HVOShould you be buying Bioventix stock or one of its competitors? The main competitors of Bioventix include Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Faron Pharmaceuticals Oy (FARN), Horizon Discovery Group plc (HZD.L) (HZD), Verona Pharma plc (VRP.L) (VRP), Arix Bioscience (ARIX), 4basebio (4BB), Circassia Group (CIR), and hVIVO (HVO). These companies are all part of the "biotechnology" industry. Bioventix vs. Silence Therapeutics PureTech Health Oxford Biomedica Faron Pharmaceuticals Oy Horizon Discovery Group plc (HZD.L) Verona Pharma plc (VRP.L) Arix Bioscience 4basebio Circassia Group hVIVO Bioventix (LON:BVXP) and Silence Therapeutics (LON:SLN) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, profitability, valuation, institutional ownership, dividends, community ranking, risk and analyst recommendations. Does the media refer more to BVXP or SLN? In the previous week, Bioventix's average media sentiment score of 0.55 beat Silence Therapeutics' score of 0.00 indicating that Bioventix is being referred to more favorably in the media. Company Overall Sentiment Bioventix Positive Silence Therapeutics Neutral Which has stronger earnings & valuation, BVXP or SLN? Bioventix has higher revenue and earnings than Silence Therapeutics. Silence Therapeutics is trading at a lower price-to-earnings ratio than Bioventix, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioventix£13.65M10.90£8.12M£154.6218.37Silence Therapeutics£11.35M0.00N/A-£48.60N/A Is BVXP or SLN more profitable? Bioventix has a net margin of 59.51% compared to Silence Therapeutics' net margin of 0.00%. Bioventix's return on equity of 69.09% beat Silence Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Bioventix59.51% 69.09% 54.07% Silence Therapeutics N/A N/A N/A Do institutionals & insiders hold more shares of BVXP or SLN? 62.3% of Bioventix shares are owned by institutional investors. 8.0% of Bioventix shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the MarketBeat Community believe in BVXP or SLN? Silence Therapeutics received 111 more outperform votes than Bioventix when rated by MarketBeat users. Likewise, 68.81% of users gave Silence Therapeutics an outperform vote while only 52.87% of users gave Bioventix an outperform vote. CompanyUnderperformOutperformBioventixOutperform Votes9252.87% Underperform Votes8247.13% Silence TherapeuticsOutperform Votes20368.81% Underperform Votes9231.19% SummaryBioventix beats Silence Therapeutics on 9 of the 11 factors compared between the two stocks. Get Bioventix News Delivered to You Automatically Sign up to receive the latest news and ratings for BVXP and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BVXP vs. The Competition Export to ExcelMetricBioventixBiotechnology IndustryMedical SectorLON ExchangeMarket Cap£148.71M£128.75M£5.38B£2.66BDividend Yield5.48%3.74%5.21%5.05%P/E Ratio18.373.4226.76134.07Price / Sales10.904,156.78389.94213,407.41Price / Cash30.8913.1938.2528.02Price / Book12.3533.146.803.79Net Income£8.12M-£91.56M£3.23B£5.88B7 Day PerformanceN/A3.29%1.52%0.38%1 Month Performance12.92%8.06%10.04%21.83%1 Year Performance-35.09%101.97%16.73%120.81% Bioventix Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BVXPBioventixN/AGBX 2,900+1.8%N/A-33.9%£151.85M£13.65M18.7612News CoverageSLNSilence TherapeuticsN/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading VolumePRTCPureTech Health1.3332 of 5 starsGBX 134.60+4.0%GBX 455+238.0%-40.3%£404.31M£521,320.79-5.52300OXBOxford Biomedica2.191 of 5 starsGBX 306.82-0.2%GBX 380+23.8%-8.1%£326.16M£98.31M-2.28891FARNFaron Pharmaceuticals OyN/AGBX 238+7.7%N/A-6.3%£319.52MN/A-6.3734Gap UpHZDHorizon Discovery Group plc (HZD.L)N/AN/AN/AN/A£302.98M£54.63M-33.55416VRPVerona Pharma plc (VRP.L)N/AN/AN/AN/A£228MN/A-1.6822Gap UpARIXArix BioscienceN/AN/AN/AN/A£183.73M£14.16M1,290.9194BB4basebioN/AGBX 1,145+1.8%GBX 1,600+39.7%-18.5%£146.67M£311,000.00-1,467.95101News CoverageCIRCircassia GroupN/AN/AN/AN/A£142.66M£27.90M3,400.00111Gap DownHVOhVIVON/AGBX 17.14-2.1%N/A-35.3%£121.27M£68.74M7.07N/AGap Down Related Companies and Tools Related Companies Silence Therapeutics Competitors PureTech Health Competitors Oxford Biomedica Competitors Faron Pharmaceuticals Oy Competitors Horizon Discovery Group plc (HZD.L) Competitors Verona Pharma plc (VRP.L) Competitors Arix Bioscience Competitors 4basebio Competitors Circassia Group Competitors hVIVO Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:BVXP) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | SponsoredThe Collapse Has Already Started — Your 401(k) Is NextThere's a major heist happening on American wealth in real time. Except this one doesn't involve masks or v...American Hartford Gold | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Elon Musk is back in the spotlight—this time for fueling a global scramble for silver. Tesla's relentless p...GoldenCrest Metals | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredTrump’s Bitcoin Reserve is No Accident…How everyday investors are building crypto wealth (step-by-step guide) Don't wait. The window for maximum g...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bioventix PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Bioventix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BVXP Stock Free BVXP Stock Alerts